Dr. Ashley Fuller, MD
NPI: 1912100116
Total Payments
$55,265
2024 Payments
$21,930
Companies
9
Transactions
68
Medicare Patients
408
Medicare Billing
$38,997
Payment Breakdown by Category
Other$46,295 (83.8%)
Travel$6,805 (12.3%)
Food & Beverage$2,166 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,295 | 18 | 83.8% |
| Travel and Lodging | $6,805 | 24 | 12.3% |
| Food and Beverage | $2,166 | 26 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $53,698 | 57 | $0 (2024) |
| SCYNEXIS, Inc. | $1,273 | 2 | $0 (2022) |
| AbbVie, Inc. | $106.56 | 2 | $0 (2019) |
| Agile Therapeutics, Inc. | $64.63 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $43.43 | 1 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $30.73 | 1 | $0 (2023) |
| HOLOGIC INC | $20.21 | 1 | $0 (2017) |
| Myovant Sciences Inc. | $16.33 | 1 | $0 (2022) |
| MAYNE PHARMA COMMERCIAL LLC | $12.80 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,930 | 27 | Astellas Pharma US Inc ($21,874) |
| 2023 | $31,888 | 34 | Astellas Pharma US Inc ($31,823) |
| 2022 | $94.94 | 3 | SCYNEXIS, Inc. ($47.98) |
| 2021 | $1,225 | 1 | SCYNEXIS, Inc. ($1,225) |
| 2019 | $94.41 | 1 | AbbVie, Inc. ($94.41) |
| 2018 | $12.15 | 1 | AbbVie, Inc. ($12.15) |
| 2017 | $20.21 | 1 | HOLOGIC INC ($20.21) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $515.00 | General |
| 08/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: Biological | ||||||
| 08/19/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.80 | General |
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Biological | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $739.80 | General |
| Category: Biological | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $205.42 | General |
| Category: Biological | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Biological | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $16.00 | General |
| Category: Biological | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Biological | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $556.69 | General |
| Category: Biological | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $401.68 | General |
| Category: Biological | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Biological | ||||||
| 05/17/2024 | GlaxoSmithKline, LLC. | BREXAFEMME (Drug) | Food and Beverage | In-kind items and services | $43.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $441.68 | General |
| Category: Biological | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Biological | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $268.15 | General |
| Category: Biological | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,090.00 | General |
| Category: Biological | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $451.68 | General |
| Category: Biological | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $217.39 | General |
| Category: Biological | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $71.75 | General |
| Category: Biological | ||||||
| 03/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $15.48 | General |
| Category: Biological | ||||||
| 01/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $775.00 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 123 | 143 | $39,049 | $12,197 |
| 2022 | 5 | 119 | 138 | $34,822 | $11,740 |
| 2021 | 5 | 108 | 121 | $33,150 | $11,061 |
| 2020 | 3 | 58 | 64 | $14,247 | $3,999 |
Total Patients
408
Total Services
466
Medicare Billing
$38,997
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 52 | $16,224 | $5,493 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 62 | $13,702 | $4,141 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,680 | $1,997 | 26.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 13 | 13 | $1,443 | $565.11 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 68 | $14,348 | $5,207 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 21 | $6,552 | $2,316 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $7,680 | $2,207 | 28.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $4,082 | $1,128 | 27.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 20 | 20 | $2,160 | $882.25 | 40.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 44 | $9,284 | $3,358 | 36.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $10,560 | $3,158 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 25 | $7,800 | $2,909 | 37.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 19 | 19 | $2,052 | $851.77 | 41.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $3,454 | $783.65 | 22.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 27 | $8,019 | $1,889 | 23.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 24 | $4,824 | $1,524 | 31.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 13 | 13 | $1,404 | $585.13 | 41.7% |
About Dr. Ashley Fuller, MD
Dr. Ashley Fuller, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912100116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Fuller, MD has received a total of $55,265 in payments from pharmaceutical and medical device companies, with $21,930 received in 2024. These payments were reported across 68 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($46,295).
As a Medicare-enrolled provider, Fuller has provided services to 408 Medicare beneficiaries, totaling 466 services with total Medicare billing of $38,997. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Obstetrics & Gynecology
- Location Seattle, WA
- Active Since 06/06/2007
- Last Updated 05/06/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1912100116
Products in Payments
- Veozah (Drug) $53,183
- Orilissa (Drug) $106.56
- Twirla (Drug) $64.63
- BREXAFEMME (Drug) $43.43
- MYFEMBREE (Drug) $30.73
- MyoSure Trial (Device) $20.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Seattle
Dr. Rod Oskouian, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2.4M
Student in an Organized Health Care Education/Training Program $2.4M
Dr. Gordana Juric-Sekhar, Md Phd, MD PHD
Student in an Organized Health Care Education/Training Program — Payments: $873,399
Student in an Organized Health Care Education/Training Program $873,399
Dr. Fernanda Musa, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $82,894
Student in an Organized Health Care Education/Training Program $82,894
George Schade, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $51,659
Student in an Organized Health Care Education/Training Program $51,659
Mr. Jia-Wei Ko, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $34,850
Student in an Organized Health Care Education/Training Program $34,850
Mr. Amir Abdul-Jabbar, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $33,317
Student in an Organized Health Care Education/Training Program $33,317